Higher BMI Increases Risk of CHD, Hypertension, Type 2 Diabetes
New findings confirm previous evidence that higher body mass index (BMI) is associated with an increased risk of cardiometabolic diseases such as hypertension, coronary heart disease and Type 2 Diabetes. The study is published in JAMA Cardiology.
Previously conducted observational studies have already established a connection between higher BMI and cardiometabolic disease risk but these studies have been unable to account for confounding by shared risk factors. The use of Mendelian randomisation overcomes these limitations.
During this study, Donald M. Lyall, Ph.D., of the University of Glasgow, Scotland, and colleagues analysed 119,859 participants and examined the association between BMI and cardiometabolic diseases and traits. 47% of the participants were men with an average age of 57 years.
Findings showed that higher BMI was associated with an increased risk of CHD, hypertension and Type 2 Diabetes. Higher BMI was also found to be associated with increased systolic and diastolic blood pressure. These findings were independent of age, sex, history of smoking and alcohol intake.
The authors believe that these findings are extremely relevant for public health policies, especially in light of rising obesity levels. BMI is an important modifiable risk factor which should be considered when identifying patients at high risk of cardiometabolic diseases.
Source: JAMA Cardiology
Image Credit: Lee Health
Published on : Thu, 6 Jul 2017
Hemodynamic measurement just got easier Task Force ® Touch CARDIO* provides a set of synchronized patient signals derived from the unique non-invasive CNAP ® finger sensor , combined with wireless 12-channel ECG. It is...
Continuous non-invasive blood pressure, cardiac output and fluid management for moderate and low-risk surgery CNAP ® Monitor provides advanced hemodynamic information from the non-invasive resusable CNAP ® finger sensor . It supports your Goal...
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...
CNAP® OEM partner solutions
The CNAP® technology is easily integrated into your product using our CNAP® OEM Partner Solutions.
INTEGRATION MADE EASY Discover our CNAP ® OEM partner solutions FULL SET OF NON-INVASIVE CONTINUOUS PATIENT SIGNALS Based on an easy-to-use dual finger sensor, the patented...